This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Peripheral Artery Disease
and you are
between 18 and 85
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This study was designed to assess the safety, tolerability and efficacy of ACZ885 on the leg artery structure and physical activity in patients with atherosclerotic peripheral artery disease and leg pain from walking.

Provided treatments

  • Drug: Canakinumab (ACZ885)
  • Drug: Placebo
Tris trial is registered with FDA with number: NCT01731990. The sponsor of the trial is Novartis Pharmaceuticals and it is looking for 38 volunteers for the current phase.
Official trial title:
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.